Please login to the form below

Not currently logged in
Email:
Password:

emotive appoints new medical director

Dr Gill Boucher joins the agency from QuintilesIMS

emotive Dr Gill Boucheremotive has appointed Dr Gill Boucher as its new medical director in a role that also sees her join the London-based agency’s senior leadership team.

Dr Boucher arrives at emotive from QuintilesIMS, where she spent seven years, most recently working as product and strategy director developing medical communications.

A qualified physician, she began her career in the NHS before taking up a position with Martindale Pharmaceuticals, where she worked in medical affairs.

Chris Edmonds, emotive’s managing director, said: “Gill is a superb addition to emotive. and strengthens an extremely high calibre senior leadership team with backgrounds from HCP, agency and client-side.

“As emotive completes its transition to a fully fledged international healthcare communications agency with a strong heritage in leveraging technologies to stimulate engagement, Gill’s experience as a practicing physician and in various roles leading teams of medical directors and writers will ensure the agency continues to deliver high-quality scientific communications.“

In her new role at emotive Dr Boucher will oversee the agency’s in-house team of medical writers and provide senior strategic direction in all disciplines of medical communications.

9th March 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics